Interleukin 10 release during endotoxaemia in chimpanzees: role of platelet-activating factor and interleukin 6

Scand J Immunol. 1996 Jan;43(1):122-5. doi: 10.1046/j.1365-3083.1996.d01-12.x.

Abstract

Interleukin (IL-)10 has been demonstrated to inhibit endotoxin-induced production of a number of pro-inflammatory cytokines. The present study sought to compare the appearances in the circulation of IL-10, IL-6 and IL-8, and to assess the roles of endogenously produced platelet-activating factor (PAF) and IL-6 in IL-10 release during endotoxaemia in chimpanzees. Intravenous injection of endotoxin (lot EC-5, 4 ng/kg, n = 8) induced a transient rise in serum IL-10 concentrations, peaking after 2 h (213 +/- 70 pg/ml; P < 0.05). No correlations existed between peak IL-10 levels, and peak IL-6 and IL-8 levels. Neither infusion of the specific PAF antagonist TCV-309 (n = 4), nor infusion of a neutralizing anti-IL-6 monoclonal antibody (n = 4) influenced endotoxin-induced IL-10 release. IL-10 release elicited by injection of endotoxin is not mediated by PAF or IL6.

Publication types

  • Comparative Study

MeSH terms

  • Animals
  • Antibodies, Monoclonal / administration & dosage
  • Endotoxins*
  • Escherichia coli*
  • Injections, Intravenous
  • Interleukin-10 / biosynthesis*
  • Interleukin-6 / biosynthesis
  • Interleukin-6 / physiology*
  • Interleukin-8 / biosynthesis
  • Isoquinolines / pharmacology
  • Pan troglodytes
  • Platelet Activating Factor / physiology*
  • Platelet Aggregation Inhibitors / pharmacology
  • Pyridinium Compounds / pharmacology
  • Tetrahydroisoquinolines*
  • Toxemia / chemically induced
  • Toxemia / immunology*

Substances

  • Antibodies, Monoclonal
  • Endotoxins
  • Interleukin-6
  • Interleukin-8
  • Isoquinolines
  • Platelet Activating Factor
  • Platelet Aggregation Inhibitors
  • Pyridinium Compounds
  • Tetrahydroisoquinolines
  • Interleukin-10
  • TCV 309